340b | News
1
archive,paged,category,category-news,category-1,paged-6,category-paged-6,ajax_fade,page_not_loaded,,qode-theme-ver-9.1.3,wpb-js-composer js-comp-ver-4.11.1,vc_responsive

News

08 Jan Modern Healthcare: All harm, no help in 340B cuts

"Now that a U.S. District Court has postponed the hospital industry's legal challenge to cutbacks in the 340B drug discount program, it falls to Congress to reverse the Trump administration's egregious new rules. Believe it or not, there's hope, since the new rules benefit no one—quite...

Read More

29 Dec Managed Care: Unfairly Targeting 340B Hospitals

"In an era of rapidly escalating prices, the 340B drug discount program remains one of the few checks to keep medicine and medical care accessible to the underserved. Contrary to the recent column, "Payers Must Develop Strategies To Overcome 340B Hurdles," it is not being exploited by...

Read More

21 Dec Townhall: Pharma’s Failed Blame Game on Drugs

"One of the most notable political eyesores of recent years has been the issue of high drug prices. Since 2015, the public has been hungry for a solution to this problem. Indeed, even in 2015, there was a level of bipartisan agreement that drug prices were...

Read More

11 Dec TribTalk: Setting the record straight on drug discounts

"We recently celebrated the 25th anniversary of the 340B Drug Pricing Program, signed into law by then-President George H.W. Bush. With strong bipartisan support, the law requires drug companies to discount their prices when they sell to clinics, hospitals and health centers that care for large...

Read More